|Last Price||Today's Change||52-Week Range||Trading Volume|
|49.89||-0.82 (-1.62%)||45.69 - 63.62||7.6 million (Below Avg)|
Market data as of 2:17PM 10/13/15. Quotes are delayed by at least 15 min.
Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma
10/13/2015 7:30 AM ET